Modal

Please choose your region

Content differs due to regional regulations.
You can switch regions at any time.

CLARITY Program continue reading →

Home
DeltaScan
Knowledge Base
News
About us
- About us
- Supervisory Board
- Investors
- Jobs
- Contact
🇪🇺 EU
- 🇺🇸 Switch to US website

Home
DeltaScan
Knowledge Base
News
About us
- About us
- Supervisory Board
- Investors
- Jobs
- Contact
🇪🇺 EU
- 🇺🇸 Switch to US website

en

English
Deutsch (German)
Nederlands (Dutch)

Contact Us

News

Topic

Investors

All Post
Press
Research
Webinar
FDA
Investors

Category

Press
Research
Webinar
FDA
Investors

Popular Posts

Webinar Recordings: Improved Delirium Management in Cardiothoracic Patients
Growth capital investment for Prolira for roll-out of brain state monitoring to hospitals
FDA Clearance of the DeltaScan® Brain State Monitor
The Delphi Delirium Management Algorithms. A practical tool for clinicians
New Validation Study

Growth capital investment for Prolira for roll-out of brain state monitoring to hospitals

Press Investors

Growth capital investment for Prolira for roll-out of brain state monitoring to hospitals

Investors Borski fund, ROM Utrecht Region, Holland Capital, Health Innovations and Oost NL together...

4 minutes read

31 January 2022

Read More

Proud sponsor of

eras-cardiac-sponsor-delirium-1

Connect.

Follow us on:

Stay informed.

Find out first about important updates and announcements by signing up to our newsletter.

The DeltaScan® Brain State Monitor is the first FDA-cleared and EU MDR certified device for detecting acute encephalopathy (acute brain failure; also defined as an indicator for brain health) and delirium, a condition affecting millions of hospitalized patients. It provides a quick and objective measurement of acute brain failure often before symptoms appear, enabling clinicians to provide immediate treatment to improve patient outcomes.

Languages / Countries

English - United States

Postal Address Europe HQ

Winthontlaan 30C, 3526 KV, Utrecht, The Netherlands

Europe HQ

+31 (0)85 060 1656

info@prolira.com

Padualaan 8, 3584 CH, Utrecht, The Netherlands

US HQ

(248) 487-6114

info@prolira.com

418 N. Main Street, Suite 200, Royal Oak, MI 48067

Other countries

Copyright © 2024 Prolira All Rights Reserved.

Prolira’s privacy statement | Cookie statement